The End of Growth at Any Cost: What the 2026 DSO Reset Demands of Operators

Hamza Asumah, MD, MBA, MPH

For most of the last decade, the DSO playbook was simple: grow. Acquire practices, expand the footprint, push the location count higher, and trust that scale would eventually sort out the operational details. Capital was cheap, multiples were rich, and momentum forgave a multitude of sins. That era is over. In 2026, the DSO market is undergoing a reset that is separating the operators who built real businesses from the ones who simply built large ones.

The signals are impossible to ignore

Two developments this year crystallized the shift. Dental Care Alliance and Affordable Care — both substantial, well-known organizations — have reportedly transitioned into lender control following restructuring challenges. When organizations of that size hit that kind of distress, it is not an isolated stumble. As one industry leader put it, these updates may signal the end of the “growth at any cost” era.

The valuation data tells the same story. At the peak, larger DSO transactions reached 13 to 16 times EBITDA. Those multiples have fallen closer to 9 to 10 times. Smaller practices, which briefly commanded around 7 times during the frenzy, have settled back toward a more traditional 5 to 6 times. For sellers who timed it wrong, that correction is painful. But it represents a return to pricing that can actually be sustained — valuations grounded in performance rather than momentum.

The demand is still there. The discipline is new.

This is not a story of collapsing appetite. Sixty-nine percent of DSOs expect to increase their acquisition activity this year. The hunger to grow has not gone anywhere.

What has changed is what happens before a deal closes. With fewer quality practices available for sale, the market has become high-demand and low-supply — and that has flipped the posture of acquirers. DSOs are becoming far more selective, placing heightened scrutiny on financials, operations, and the credibility of performance projections. The casual roll-up is dead. Today’s buyer performs real due diligence and insists on fair valuations to avoid overpaying, which is precisely what drove the pricing reset in the first place.

In other words, the market is doing what undisciplined operators failed to do on their own: forcing rigor into the process.

The strategic pivot: from expansion to infrastructure

The clearest through-line in how serious DSOs are repositioning is a deliberate move away from network expansion and toward operational depth. The lesson the distressed cases taught everyone is direct: organizations that grow rapidly without the right support systems — operational infrastructure and clinical alignment — run into trouble that scale only magnifies.

Growth, it turns out, exposes every weakness. A practice with shaky systems and a fuzzy grasp of its own numbers does not get healthier when you bolt 20 more locations onto it. It gets more fragile, because now the same weaknesses are replicated across a wider footprint with more debt attached.

So the priorities are inverting. Instead of chasing a scattered national presence, leading DSOs are prioritizing regional density — clusters of locations that share staff, referrals, marketing, and management overhead. Instead of expansion for its own sake, they are investing in technology, leadership development, and the financial models that support sustained, rather than explosive, growth. The question has shifted from “how many locations can we add?” to “how well does each location actually run?”

Technology as a discipline, not a gadget

Within that infrastructure focus, technology has graduated from a nice-to-have to a genuine source of operational and financial leverage — but only when deployed with discipline.

The ROI is becoming measurable. AI-assisted diagnostics have produced improvements of 20% or more in patient case acceptance rates. With 91% of practices struggling to recruit hygienists, workflow automation has shifted from optional to essential — it is one of the few levers that increases capacity without requiring scarce clinical labor.

But technology cuts both ways, and undisciplined deployment backfires. When teams have to fight their own systems to get the job done, it accelerates burnout and makes retention harder — outdated billing and practice-management systems are themselves a driver of the staffing crisis. Buying software is not a strategy. Integrating it into clean workflows that make the team’s day easier, rather than harder, is.

What operators should take from this

The 2026 reset rewards one thing above all others: operational discipline. Every theme converges on it. Disciplined acquirers are surviving the M&A correction. Disciplined operators are retaining staff through the squeeze. Disciplined technology adoption is producing real returns while sloppy adoption deepens burnout.

For physician-executives and operators building in this environment, the implication is clarifying rather than discouraging. The market is no longer grading on momentum. It is grading on whether you know your numbers, whether your systems hold up under scale, and whether each location is a genuinely well-run business or just a line on a growth chart.

That is a harder game than the one played from 2020 to 2024. It is also a fairer one — and for operators who actually know how to run a business, it is the most favorable competitive landscape in years. The competitors who only knew how to grow are now being tested on whether they ever learned to operate. Many will not pass. The ones who did the unglamorous work of building infrastructure before they needed it are about to find out it was the most valuable thing they ever did.

The growth-at-any-cost era is finished. The build-it-right era has begun.